CDNA Q1 2018 Earnings — CareDx, Inc Revenue & Financial Results | Market Cap Arena

CDNACareDx, Inc

$858M

Q1 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$14M+21.3% YoY

Gross Profit

$8M54.6% margin

Operating Income

-$5M-37.3% margin

Net Income

-$9M-63.8% margin

EPS (Diluted)

$-0.30

QoQ Revenue Growth

+12.4%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$706,000

Balance Sheet

Total Assets

$79M

Total Liabilities

$46M

Stockholders' Equity

$33M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$12M	+21.3%
Gross Profit	$8M	$6M	+23.7%
Operating Income	-$5M	-$9M	+38.7%
Net Income	-$9M	-$6M	-61.3%

Revenue Segments

Post Transplant

$21M76%

Pre Transplant

$7M24%

Geographic Segments

Rest Of The World

$331,00082%

AUSTRALIA

$74,00018%